Bosnia-Herzegovina opens the door to medical cannabis

On December 29, the Council of Ministers of Bosnia and Herzegovina adopted a decision legalizing the cannabis for medical purposes, thereby creating a regulated framework that will give patients access to treatments that have long been confined to the gray market or foreign healthcare systems.

This measure, called for over the past several years, brings the Balkan nation into line with a growing majority of European countries and its Balkan neighbors who have recognized the therapeutic potential of cannabis-based medications, while maintaining a cautious and closely supervised approach.

From a ban to strict medical supervision

Until now, cannabis, its resins, extracts, and tinctures were among the substances prohibited under Bosnian law. The new decision reclassifies these products into a category subject to a strict monitoring, explicitly paving the way for their medical use. According to the Council, this reclassification allows for the legal prescription and controlled distribution of cannabis-based treatments within the healthcare system.

The framework introduces several safeguards designed to balance patient access and regulatory oversight. These include, in particular, a prescription required, comprehensive record-keeping requirements, regulated production and distribution channels, and clear restrictions on storage and sales. Monitoring systems will also be put in place to ensure quality control and prevent diversion.

Implementation will not be immediate. The authorities have indicated that licensing rules, oversight mechanisms, and secondary regulations will be phased in gradually, and that additional regulations will be established by the Medicines Agency and regional health authorities.

Years of advocacy led to this decision

This vote didn't just come out of nowhere. It comes after years of pressure from patients, healthcare professionals, and lawmakers, many of whom argued that denying access to medical cannabis caused unnecessary suffering for people with serious illnesses.

One of the most vocal advocates, Saša Magazinović, a member of the Social Democratic Party in the Bosnian Parliament, announced publicly He welcomed this decision and described it as the culmination of a long and often frustrating battle.

«After years of struggle, obstruction, and perseverance… FINALLY!» wrote Mr. Magazinović. «The Council of Ministers has adopted a decision to legalize cannabis for medical purposes.»

He recalled the first parliamentary hearings during which patients had described the impact of cannabis oil on conditions such as multiple sclerosis and other serious illnesses.

«I think back to the first conference we organized at Parliament, where we heard testimonials from people who had been helped by cannabis oil,» he said, adding that those moments had helped shift political attitudes.

Magazinović made a point of congratulating Irfan Ribić, a student at the Sarajevo Academy of Dramatic Arts, who has spoken publicly about his use of cannabis oil to treat multiple sclerosis.

«A big thank you to Irfan Ribic, who has been my driving force in getting me involved in the fight to legalize cannabis for medical purposes,» said Magazinović.

Despite the symbolic importance of the vote, policymakers are careful to emphasize that the real work begins now. The detailed rules governing prescriptions, production standards, and patient eligibility have yet to be finalized.

«The most important step has been taken, but the devil is in the details,» Magazinović warned. «We’re moving forward, but it’s much easier now.»